Cormorant Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-296,000
| Closed | -$10.4M | – | 64 |
|
|
2023
Q1 | $10.4M | Hold |
296,000
| – | – | 0.69% | 37 |
|
|
2022
Q4 | $13.6M | Hold |
296,000
| – | – | 0.91% | 34 |
|
|
2022
Q3 | $14.3M | Sell |
296,000
-104,000
| -26% | -$5.04M | 1% | 35 |
|
|
2022
Q2 | $15.7M | Hold |
400,000
| – | – | 1.19% | 26 |
|
|
2022
Q1 | $14.7M | Sell |
400,000
-300,000
| -43% | -$11M | 1.13% | 26 |
|
|
2021
Q4 | $31.9M | Sell |
700,000
-300,000
| -30% | -$13.7M | 1.9% | 15 |
|
|
2021
Q3 | $35.7M | Buy |
+1,000,000
| New | +$35.7M | 1.45% | 19 |
|